Yamashita, Yoji <br/><br/>
Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts.  [electronic resource] 

 -  Neuro-oncology  Jan 2007 
 - 20-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-8517 
<br/><br/><label>Standard No.: </label>10.1215/15228517-2006-016  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Brain Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Doxorubicin--administration & dosage<br/>Drug Delivery Systems<br/>Glioblastoma--drug therapy<br/>Humans<br/>Male<br/>Polyethylene Glycols--administration & dosage<br/>Rats<br/>Rats, Nude<br/>Rats, Sprague-Dawley<br/>Survival Rate<br/>Topoisomerase I Inhibitors<br/>Topoisomerase II Inhibitors<br/>Topotecan--administration & dosage<br/>Xenograft Model Antitumor Assays